Sensivision is a medical device start-up focused on Neonatal segment. We focus on addressing critical care challenges in Newborns. Currently we are developing device solutions to diagnose, treat and monitor Birth Asphyxia complications in Newborns resulting in death or life long brain damages in Newborns.
Our treatment device aims to provide effective and affordable treatment to a birth asphyxia complication called Hypoxic Ischemic Encephalopathy (HIE) which results in high numbers of morbidity and mortality globally every year.
Our Diagnosis solution through monitoring the brain electrical activity as well as brain tissue oxygenation, enables early diagnosis of Asphyxia thus arresting brain damage by early start of treatment.